David Shaw’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-2,100
Closed -$638K – 5173
2025
Q4
$638K Buy
2,100
+500
+31% +$164K ﹤0.01% 3803
2025
Q3
$545K Hold
1,600
– – ﹤0.01% 3821
2025
Q2
$387K Buy
+1,600
New +$392K ﹤0.01% 3754
2022
Q2
– Sell
-6,200
Closed -$1.17M – 5853
2022
Q1
$1.17M Hold
6,200
– – ﹤0.01% 3776
2021
Q4
$1.68M Buy
+6,200
New +$2.09M ﹤0.01% 3512

Other funds holding ONC

David Shaw's ONC Position: Q3 2026 in Review

David Shaw opened a new position in BeOne Medicines (ONC) in Q3 2026: 745 shares worth $273K. The stake represents ﹤0.01% of the portfolio and ranks #4528 among its holdings. This is a return to the name: David Shaw previously reported a position in ONC as recently as Q2 2025.

David Shaw first reported a position in ONC in Q1 2017 and has held it in 11 quarters since. The position peaked at $38.3M in Q2 2025. 325 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • David Shaw held 745 shares of BeOne Medicines worth $273K as of Q3 2026.
  • BeOne Medicines was a new David Shaw position in Q3 2026.
  • BeOne Medicines made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4528 holding.
  • David Shaw first reported a position in BeOne Medicines in Q1 2017 and has held it in 11 quarters since.
  • David Shaw's BeOne Medicines position peaked at $38.3M in Q2 2025.
  • 325 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.